Question · asked by 1 review
Pregabalin 600 mg vs placebo: Lack of efficacy withdrawal
- Population
- adults with moderate or severe pain associated with postherpetic neuralgia
- Intervention
- Pregabalin 600 mg
- Comparison
- placebo
- Outcome
- Lack of efficacy withdrawal
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Pregabalin 600 mg vs placebo Lack of efficacy withdrawal · adults with moderate or severe pain associated with postherpetic neuralgia Pregabalin for neuropathic pain in adults (2019) · Cochrane Headline outcomes only | no estimate extracted | 4 studies · 732 participants | High |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Pregabalin for neuropathic pain in adults 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Pregabalin 600 mg vs placebo · adults with moderate or severe pain associated with painful diabetic neuropathy · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.